Heyu Biological Technology Corp Overview
Industry: Medical Devices
Sector: Healthcare
Heyu Biological Technology Corporation, together with its subsidiaries, engages in research, development, and manufacturing of healthcare equipment. The company is currently focused on developing Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber. The company was formerly known as Pacific WebWorks, Inc. and changed its name to Heyu Biological Technology Corporation in June 2018. Heyu Biological Technology Corporation was incorporated in 1987 and is based in Xiamen, the People's Republic of China.
Heyu Biological Technology Corp is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review Heyu Biological Technology Corp in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
Heyu Biological Technology Corp Competitors
Heyu Biological Technology Corp operates in the Medical Devices industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans